Atlas Trials

Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer

Clinical trial NCT02353832 · COMPLETED

Trial details

NCT number
NCT02353832
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-11-06
Primary completion
2018-01-29
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.